START Midwest

Midwest

Grand Rapids, MI

Sorting 1 by

Accepting patients

OPN-662

A Phase 1b, Dose Escalation/Dose Expansion, Multicenter, Open-Label Study to Assess the Safety and Tolerability of OPN-6602 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and/or Refractory Multiple Myeloma
Learn more
  • BET Inhibitor
  • Phase 1